The presence of specific autoantibodies-anti-Ro/SSA (anti-Ro/SS-A) and anti-La/SSB (anti-La/SS-B)-provides an important serological indicator of SS, with approximately 60-70% of SS patients testing positive for these antibodies [10]. Here, CALR is linked to synovial sarcoma.